Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (отвара нови прозор)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Извор‎: Hemoglobin 2014;38(1):44-8.

Индекс‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (отвара нови прозор)

Hydroxyurea in thalassemia intermedia--a promising therapy. (отвара нови прозор)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Извор‎: Ann Hematol 2005;84(7):441-6.

Индекс‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (отвара нови прозор)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (отвара нови прозор)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Извор‎: J Clin Pathol 2010;63(2):147-50.

Индекс‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (отвара нови прозор)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (отвара нови прозор)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Извор‎: Eur J Haematol 2009;82(3):213-8.

Индекс‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (отвара нови прозор)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (отвара нови прозор)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Извор‎: Eur J Haematol 2010;84(1):52-8.

Индекс‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (отвара нови прозор)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (отвара нови прозор)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Извор‎: Blood Cells Mol Dis 2000;26(5):453-66.

Индекс‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (отвара нови прозор)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (отвара нови прозор)

Perrine SP.

Извор‎: Pediatr Ann 2008;37(5):339-46.

Индекс‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (отвара нови прозор)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (отвара нови прозор)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Извор‎: Ann N Y Acad Sci 2005;1054:250-6.

Индекс‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (отвара нови прозор)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (отвара нови прозор)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Извор‎: Acta Haematol 2004;111(4):189-95.

Индекс‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (отвара нови прозор)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (отвара нови прозор)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Извор‎: Blood Purif 2004;22(5):453-60.

Индекс‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (отвара нови прозор)

The role of recombinant human erythropoietin in the treatment of thalassemia. (отвара нови прозор)

Rachmilewitz EA, Aker M.

Извор‎: Ann N Y Acad Sci 1998;850:129-38.

Индекс‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (отвара нови прозор)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (отвара нови прозор)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Извор‎: Br J Haematol 2011;154(2):281-4.

Индекс‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (отвара нови прозор)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (отвара нови прозор)

Thein SL.

Извор‎: Blood Rev 2012;26 Suppl 1:S35-9.

Индекс‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (отвара нови прозор)